Epidemiology of bladder cancers in Fars province, Southern Iran (2003-2008)

Journal of Kerman University of Medical Sciences

Volumn 20, Issue 4, 2013, Pages 387-394

  Farahmand, M ^a   Almasi Hashiani, A ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Epidemiology; Incidence; Urinary bladder neoplasms

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER REGISTRY; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE;

EID: 84926224575     PISSN: 10239510     EISSN: 20082843     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Alsayyad J, Hamadeh R. Cancer incidence among the Bahraini population: A five-year (1998-2002) experience. Ann Saudi Med 2007;27(4): 251-8.
2. Díaz Model P, Osella AR, Aballay LR, Muñoz SE, Lantieri MJ, Butinof M, et al. Cancer incidence pattern in Cordoba, Argentina. Eur J Cancer Prev 2009; 18(4): 259-66.
3. Farahmand M, Almasi-Hashiani A, Mohammad Beigi A, Raei-Dehaghi M, Ajdari A. The Epidemiology of Childhood Hematopoietic and Reticuloendothelial Cancer based on Fars Province Cancer Registry Data System, (2001-08). Daneshvar Medicine 2011;18: 27-34 [Persian].
4. Farahmand M, Almasi-Hashiani A, Hassanzade J, Moghadami M. Childhood cancer epidemiology based on cancer registry's data of Fars province of Iran. Koomesh 2011;13:8-14.
5. Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H, Bahadori M. Cancer Registry in Iran: a brief overview. Arch Iranian Med 2008;11(5): 577-80.
6. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
7. Cabanes A, Vidal E, Aragonés N, Pérez-Gómez B, Pollán M, Lope V, et al. Cancer mortality trends in Spain: 1980-2007. Annals of Oncology 2010; 21(suppl 3): iii14-iii20.
8. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconemic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61(4): 212-36.
9. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol 2009; 20(3): 556-63.
10. Fedewa SA, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, et al. Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol 2009; 33(3-4): 176-81.
11. Grasso M. Bladder Cancer: A Major Public Health Issue. European Urology Supplements 2008; 8(7): 510-15.
12. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46(4): 765-81.
13. Sadgadi AR, Malekzadeh R, Derakhshan M. H, Sepehr AR, Noraei M, Sotoudeh M, et al. Cancer occurrence in Ardabil: Results of a population-based Cancer Registry from Iran. Int J Cancer 2003; 107(1): 113-18.
14. Mehrabani D, Tabei SZ, Heydari ST, Shamsinia SJ, Shokrpour N, Amini M, et al. Cancer Occurrence in Fars Province, Southern Iran. IRCMJ 2008; 10: 314-22.
15. Human Development Report 2011, Explanatory note on 2011 HDR composite indices; Islamic Republic of Iran. available from: http://hdrstats.undp.org/images/ explanations/IRN.pdf
16. Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, et al. Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a populationbased study. Cancer Lett 2005;219(1):63-9.
17. Ebadi M, Vahdaninia M, Azin A, Aeenparast A, Omidvari S, Jahangiri K, et al. Prevalence of tobacco consumption: Iranian health perception survey. Payesh 2011; 10(3): 365-72 [Persian].